Yahoo
NasdaqCM - Nasdaq Real Time Price USD

Compass Therapeutics, Inc. (CMPX)

0.7865 +0.0303 (+4.01%)
At close: October 30 at 4:00:01 PM EDT
0.8000 +0.0135 (+1.72%)
After hours: October 30 at 6:40:49 PM EDT
Trade CMPX on Coinbase
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
0
0
850
0
0
Operating Expense
81,085
72,839
57,475
50,363
41,655
Operating Income
-81,085
-72,839
-56,625
-50,363
-41,655
Net Non Operating Interest Income Expense
7,689
6,400
7,300
7,900
2,360
Other Income Expense
--
-50
-50
-31
70
Pretax Income
-73,446
-66,489
-49,375
-42,494
-39,225
Tax Provision
--
--
0
0
0
Net Income Common Stockholders
-73,446
-66,489
-49,375
-42,494
-39,225
Diluted NI Available to Com Stockholders
-73,446
-66,489
-49,375
-42,494
-39,225
Basic EPS
-0.39
-0.42
-0.36
-0.33
-0.37
Diluted EPS
-0.39
-0.42
-0.36
-0.33
-0.37
Basic Average Shares
181,865.5000
157,695
137,152.7780
127,027
105,186
Diluted Average Shares
181,865.5000
157,695
137,152.7780
127,027
105,186
Total Operating Income as Reported
-81,085
-72,839
-56,625
-50,363
-41,655
Total Expenses
81,085
72,839
57,475
50,363
41,655
Net Income from Continuing & Discontinued Operation
-73,446
-66,489
-49,375
-42,494
-39,225
Normalized Income
-73,446
-66,489
-49,375
-42,494
-39,295
Interest Income
7,689
6,400
7,300
7,900
2,360
Interest Expense
--
--
--
--
0
Net Interest Income
7,689
6,400
7,300
7,900
2,360
EBIT
-81,085
-72,839
-56,625
-50,363
-41,655
EBITDA
-79,600
-71,367
-54,872
-48,473
-39,751
Reconciled Depreciation
1,485
1,472
1,753
1,890
1,904
Net Income from Continuing Operation Net Minority Interest
-73,446
-66,489
-49,375
-42,494
-39,225
Total Unusual Items Excluding Goodwill
0
--
--
0
70
Total Unusual Items
0
--
--
0
70
Normalized EBITDA
-79,600
-71,367
-54,872
-48,473
-39,821
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2022 - 4/5/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: